China SXT Pharmaceuticals Inc
NASDAQ:SXTC

Watchlist Manager
China SXT Pharmaceuticals Inc Logo
China SXT Pharmaceuticals Inc
NASDAQ:SXTC
Watchlist
Price: 1.51 USD -1.37% Market Closed
Market Cap: 175.2m USD

Operating Margin
China SXT Pharmaceuticals Inc

-96.2%
Current
-181%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-96.2%
=
Operating Profit
-1.7m
/
Revenue
1.7m

Operating Margin Across Competitors

No Stocks Found

China SXT Pharmaceuticals Inc
Glance View

Market Cap
175.2m USD
Industry
Pharmaceuticals

China Sxt Pharmaceuticals, Inc. is a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 96 full-time employees. The company went IPO on 2019-01-04. The firm develops, manufactures and sells three types of TCMP products: advanced TCMP, fine TCMP and regular TCMP, and TCM Homologous Supplements (TCMHS) products. The firm sells its TCMP products under three brand names such as Suxuangtang, Hui Chun Tang and Tong Ren Tang. Most of its products are sold on a prescription basis across China.

SXTC Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-96.2%
=
Operating Profit
-1.7m
/
Revenue
1.7m
What is the Operating Margin of China SXT Pharmaceuticals Inc?

Based on China SXT Pharmaceuticals Inc's most recent financial statements, the company has Operating Margin of -96.2%.

Back to Top